Gene · 9173
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2. | ERJ Open Res | 2023 | 37868151 | PubTator, text mining | PubMed |
| The role of inflammation in autoimmune disease: a therapeutic target. | Front Immunol | 2023 | 37859999 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies. | Pathol Res Pract | 2023 | 37857034 | PubTator, text mining | PubMed |
| Asthma Phenotypes in the Era of Personalized Medicine. | J Clin Med | 2023 | 37834850 | PubTator, text mining | PubMed |
| Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2023 | 37834081 | PubTator, text mining | PubMed |
| Sensing of protease activity as a triggering mechanism of Th2 cell immunity and allergic disease. | Front Allergy | 2023 | 37810200 | PubTator, text mining | PubMed |
| The cardioprotective effect of Shengmai Zhenwu decoction on patients with chronic heart failure based on the levels of soluble interleukin 1 receptor-like 1. | Heliyon | 2023 | 37810073 | PubTator, text mining | PubMed |
| Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin. | Front Immunol | 2023 | 37809094 | PubTator, text mining | PubMed |
| Association of soluble suppression of tumorigenicity 2 protein with new-onset atrial fibrillation in patients with acute ST-segment elevation myocardial infarction undergoing primary PCI. | Front Cardiovasc Med | 2023 | 37808879 | PubTator, text mining | PubMed |
| IL-33 priming and antigenic stimulation synergistically promote the transcription of proinflammatory cytokine and chemokine genes in human skin mast cells. | BMC Genomics | 2023 | 37798647 | PubTator, text mining | PubMed |
| The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. | Front Immunol | 2023 | 37781372 | PubTator, text mining | PubMed |
| Macroarray expression analysis of cytokines and prostaglandin metabolism-related genes in chronic rhinosinusitis. | J Allergy Clin Immunol Glob | 2023 | 37779524 | PubTator, text mining | PubMed |
| Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation. | Int J Mol Sci | 2023 | 37762349 | PubTator, text mining | PubMed |
| Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer. | Int J Mol Sci | 2023 | 37762328 | PubTator, text mining | PubMed |
| Genomics of Treatable Traits in Asthma. | Genes (Basel) | 2023 | 37761964 | PubTator, text mining | PubMed |
| Analytical Performance of a Novel Latex Turbidimetric Immunoassay, "Nanopia TARC", for TARC/CCL17 Measurement: A Retrospective Observational Study. | Diagnostics (Basel) | 2023 | 37761302 | PubTator, text mining | PubMed |
| Biomarkers in IBD: What to Utilize for the Diagnosis? | Diagnostics (Basel) | 2023 | 37761298 | PubTator, text mining | PubMed |
| Vitamin D Influences the Activity of Mast Cells in Allergic Manifestations and Potentiates Their Effector Functions against Pathogens. | Cells | 2023 | 37759494 | PubTator, text mining | PubMed |
| The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. | Cells | 2023 | 37759430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9173/papers?page=14